Maruti Eeco used in Pulwama terror attack, owner on the run: NIA

Agencies
February 26, 2019

New Delhi, Feb 26: A Maruti Eeco minivan was used in the Pulwama terror attack and it was bought by a Jaish-e-Mohammed operative just 10 days before the February 14 strike that claimed the lives of 40 CRPF personnel, the National Investigation Agency (NIA) said Monday.

The JeM operative, identified as Sajjad Bhat, a resident of Bijbehara in south Kashmir, has since been on the run and is believed to have become an active militant now, an NIA spokesman said.

The spokesman termed this as a "significant breakthrough" in the investigation into the terror attack.

Piecing together remnants of the vehicle recovered from the scene of the blast, the NIA investigators, with the support of forensic and automobile experts, have been able to identify the vehicle as a Maruti Eeco having chassis number MA3ERLF1SOO183735 and engine number G12BN164140, the spokesman said.

The vehicle was sold to Mohammed Jaleel Ahmed Haqani, a resident of Heaven Colony in Anantnag in 2011, and subsequently it changed hands seven times and finally reached Sajjad Bhat, a student of Siraj-ul-Uloom, Shopian.

The vehicle was purchased by Sajjad Bhat on February 4, the spokesman said.

Raids were conducted by a team of NIA and police at his house on Saturday but Sajjad was not present.

He has reportedly joined Jaish-e-Mohammed and his photograph also appeared on social media where he is seen holding weapons.

The NIA, a central agency established by the government to combat terror, took over the probe into the Pulwama attack from the Jammu and Kashmir Police on February 20 and re-registered the case.

NIA Director General Y C Modi, accompanied by senior officers of the agency, has visited the site of the attack, 33 km from Srinagar, where he was briefed by the police and the Central Reserve Police Force (CRPF).

The state police had registered a case at the Awantipora police station on February 14 after a suicide bomber rammed his explosive-laden vehicle into a CRPF bus, which was part of a 78-vehicle convoy carrying over 2,500 personnel from Jammu to Srinagar.

The NIA has already gathered crucial material from the blast site in Lethpora in Pulwama district of south Kashmir and has been involved in the questioning of around a dozen people detained by the police following the blast, officials said.

The NIA is probing planning and execution of the terror attack, the second such strike in three decades of militancy in the state. In 2000, a 17-year-old Kashmiri boy had blown himself outside the Srinagar-based army cantonment, killing two Army men.

Comments

Ansar balli
 - 
Tuesday, 26 Feb 2019

One man killed 47 army,.. this is very very insult to our country, in abroad people are laughing on our capability.
and some hindutva activists who put big big poster of lion and say they are lion but in reallity thet are the cowards, they dont have courage to go to border and face the real terror but they attack innocent indian muslim who is weak..
Jai Hind

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 22,2020

New Delhi, Mar 22: The total number of novel coronavirus cases in India rose to 341 on Sunday after fresh cases were reported from various parts of the country, the Union Health Ministry said.

The total includes 41 foreign nationals and five deaths, the latest being reported from Maharashtra, taking the death toll in the state to two.

Delhi, Karnataka and Punjab have reported one death each so far. Twenty-four others have been cured/discharged/migrated.

The figure of 341 cases include 63 cases in Maharashtra, which has reported the highest number of COVID-19 cases, including three foreigners.

Kerala has reported 52 cases, including seven foreign nationals.

Delhi has reported 27 positive cases, including a foreigner, while Uttar Pradesh has recorded 25 cases, including a foreigner.

Telangana has reported 21 cases, including 11 foreigners. Rajasthan has reported 24 cases, including two foreigners.

In Haryana, there are 17 cases, which include 14 foreigners.

Karnataka has 20 coronavirus patients. Punjab and Ladakh have 13 cases each. Gujarat has 14 cases while Tamil Nadu has 6 cases, which includes 2 foreigners. Chandigarh has five cases.

Madhya Pradesh, Jammu and Kashmir, and West Bengal reported four cases each. Andhra Pradesh and Uttarakhand have reported three cases each. Odisha and Himachal Pradesh reported 2 cases each.

Puducherry and Chhattisgarh have reported one case each.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 6,2020

Mumbai, Mar 6: Harried Yes Bank depositors rushed to ATMs to withdraw cash but faced multitude of problems including closed down machines and long queues, after the RBI placed the bank under a moratorium, capping maximum withdrawals at Rs 50,000 per account for a month.

Aggravating the problems of depositors were difficulties accessing the internet banking channel, which ensured that they can't transfer the funds online as well. At an ATM in south Mumbai's Horniman Circle, with the RBI headquarters overlooking it, the shutters were pulled down.

The guard on duty said the machine was non-operational before he reported to work late in the evening and he was ordered to shut it after 2200 hrs. In the residential area of suburban Chembur, one ATM was dispensing cash but had a long queue of anxious depositors.

One man said it was still possible to withdraw up to Rs 50,000 in multiple transactions from the machine.

However, another machine nearby had run dry within minutes of the RBI announcement, a woman said.

The regulatory actions, undertaken by the RBI and the government, came hours after finance ministry sources confirmed that SBI was directed to bail out the troubled lender.

For the next month, Yes Bank will be led by the RBI-appointed administrator Prashant Kumar, an ex-chief financial officer of SBI.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.